Javascript must be enabled to continue!
Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
View through CrossRef
Abstract
Background: Familial benign chronic pemphigus, also known as Hailey-Hailey disease (HHD), is a clinically rare bullous Dermatosis. However the mechanism has not been clarified. The study aim to detect novel mutations in exons of ATP2C1 gene in HHD patients; to explore the possible mechnism of HHD pathogenesis by examining the expression profile of hSPCA1, miR-203, p63, Notch1 and HKⅡ proteins in the skin lesions of HHD patients. Methods: Genomic DNA was extracted from peripheral blood of HHD patients. All exons of ATP2C1 gene in HHD patients were amplified by PCR and the products were purified and sequenced. All related signaling proteins of interest were stained by using skin lesion tissues from HHD patients and miR-203 levels were also determined. Results: One synonymous mutation c.G2598A (in exon 26), one nonsense mutation c.C635A and two missense mutations c.C1286A (p.A429D) and c. A1931G (p. D644G) were identified. The nonsense mutation changed codon UCG to stop codon UAG, causing a premature polypeptide chain of the functional region A. The two missense mutations were located in the region P (phosphorylation region) and the Mn binding site of hSPCA1. The level of hSPCA1 was significantly decreased in HHD patients compared to the normal human controls, accompanied by an increase of miR-203 level and a decrease of p63 and HKⅡ levels. Conclusion: In our study, we found four mutations in HHD. Meanwhile we found increase of miR-203 level and a decrease of p63 and HKⅡ levels. In addition, Notch1, which was negatively regulated p63, is downregulated. These factors may be involved in the signaling pathways of HHD pathogenesis. Our data showed that both p63 and miR-203 may have significant regulatory effects on Notch1 in the skin.
Springer Science and Business Media LLC
Title: Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
Description:
Abstract
Background: Familial benign chronic pemphigus, also known as Hailey-Hailey disease (HHD), is a clinically rare bullous Dermatosis.
However the mechanism has not been clarified.
The study aim to detect novel mutations in exons of ATP2C1 gene in HHD patients; to explore the possible mechnism of HHD pathogenesis by examining the expression profile of hSPCA1, miR-203, p63, Notch1 and HKⅡ proteins in the skin lesions of HHD patients.
Methods: Genomic DNA was extracted from peripheral blood of HHD patients.
All exons of ATP2C1 gene in HHD patients were amplified by PCR and the products were purified and sequenced.
All related signaling proteins of interest were stained by using skin lesion tissues from HHD patients and miR-203 levels were also determined.
Results: One synonymous mutation c.
G2598A (in exon 26), one nonsense mutation c.
C635A and two missense mutations c.
C1286A (p.
A429D) and c.
A1931G (p.
D644G) were identified.
The nonsense mutation changed codon UCG to stop codon UAG, causing a premature polypeptide chain of the functional region A.
The two missense mutations were located in the region P (phosphorylation region) and the Mn binding site of hSPCA1.
The level of hSPCA1 was significantly decreased in HHD patients compared to the normal human controls, accompanied by an increase of miR-203 level and a decrease of p63 and HKⅡ levels.
Conclusion: In our study, we found four mutations in HHD.
Meanwhile we found increase of miR-203 level and a decrease of p63 and HKⅡ levels.
In addition, Notch1, which was negatively regulated p63, is downregulated.
These factors may be involved in the signaling pathways of HHD pathogenesis.
Our data showed that both p63 and miR-203 may have significant regulatory effects on Notch1 in the skin.
Related Results
Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
Abstract
Background: Familial benign chronic pemphigus, also known as Hailey-Hailey disease (HHD), is a clinically rare bullous Dermatosis. However the mechanism has not be...
Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
Abstract
Background: Familial benign chronic pemphigus, also known as Hailey-Hailey disease (HHD), is a clinically rare bullous Dermatosis. However the mechanism has not be...
Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
Abstract
Background: Familial benign chronic pemphigus, also known as Hailey-Hailey disease (HHD), is a clinically rare bullous Dermatosis. However the mechanism has not be...
Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
Abstract
Background: Familial benign chronic pemphigus, also known as Hailey-Hailey disease (HHD), is a clinically rare bullous Dermatosis. However the mechanism has not be...
Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
Identification of ATP2C1 mutations in the patients of Hailey-Hailey disease
Abstract
Background: Familial benign chronic pemphigus (OMIM 169600), also known as Hailey-Hailey disease (HHD), is a clinically rare bullous Dermatosis. However the mechan...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract
Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...
Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)
Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)
Abstract
Introduction
Higher-risk myelodysplastic syndromes (MDS) progress to secondary acute myeloid leukemia (sAML) within mon...
Distinct Profile of FLT3 Mutations in Brazil.
Distinct Profile of FLT3 Mutations in Brazil.
Abstract
Mutations in the tyrosine kinase receptor FLT3 are the most common molecular abnormality in acute myeloid leukemia (AML) being detected in about 30% of AML ...

